2.2 Schedules 2 & 3 (Pharmacy & Pharmacist Only Medicines)

2.2 Schedules 2 & 3 (Pharmacy & Pharmacist Only Medicines)

Quick Answer: Under the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP / Poisons Standard), Schedule 2 medicines are Pharmacy Medicines available from a pharmacy with advice available, while Schedule 3 medicines are Pharmacist Only and must be supplied with pharmacist professional involvement. Intern exam items often test assessment, counselling, quantity/age limits, and the error of treating S3 like ordinary OTC.

Medicine scheduling in Australia balances public access with risk. Community pharmacists are the legal and professional gatekeepers for many non-prescription scheduled medicines. Standard 1.3 expects you to apply schedule rules as national principles while recognising that state and territory poisons legislation implements SUSMP with local detail (especially recording and pseudoephedrine controls).

Scheduling Framework at a Glance

Scheduling is about risk and required professional oversight, not about whether a product is "strong" in a casual sense. A low-dose analgesic can be unscheduled or S2 depending on pack size and presentation; the same active ingredient can sit in different schedules at different strengths or pack sizes.

Schedule 2 — Pharmacy Medicine

Schedule 2 medicines are intended to be available from pharmacies so that people can still obtain them without a prescription, while having access to professional advice. In practice this means:

• Supply occurs in a pharmacy environment (not as unrestricted general retail for that scheduled presentation)
• Pharmacy staff can assist, and a pharmacist is available for advice when needed
• Storage and display must comply with local requirements (often allowing public access within the pharmacy under defined conditions, depending on jurisdiction and product)
• Advertising rules are more controlled than for unscheduled goods

Professional role for S2: Even when legislation does not force a full pharmacist interview for every S2 sale, competency standards still expect safe recommendation: right product, right person, red-flag screening for referral, and counselling on dose and duration. Interns should not treat S2 as "no clinical thought required".

Practical S2 Assessment Habits

Use a short structured approach (many workplaces teach variations of WHAT/WWHAM-style tools):

1. Who is the medicine for (age, pregnancy, comorbidities)?
2. What are the symptoms and duration?
3. How severe, and any red flags needing referral?
4. Actions already taken (other medicines, non-drug care)?
5. Medicines currently used (interactions, duplication)?

Document workplace-required notes for complex recommendations and always know when to escalate to the pharmacist-in-charge if you are still under supervision arrangements that require it.

Schedule 3 — Pharmacist Only Medicine

Schedule 3 medicines require a higher level of professional control. Core principles:

• Supply must be by a pharmacist (or as specifically allowed under local law in narrow circumstances—exam answers should default to pharmacist supply with professional involvement)
• The pharmacist must make a professional assessment that supply is appropriate
• Counselling is expected so the person can use the medicine safely
• Some S3 medicines have recording, quantity, age, or ID requirements
• Direct public self-selection is not the intended model for S3; storage is typically more restricted than S2

Pharmacist Assessment Obligations Before S3 Supply

Before handing over an S3 medicine, the pharmacist should be able to justify:

If assessment fails, refuse supply, explain professionally, offer alternatives or referral, and document as required. Refusal is a legal and ethical tool, not a customer-service failure.

Common S3 Classes (Exam-Relevant Examples)

Exact product scheduling can change with TGA decisions and pack-size rules; learn classes and principles, then confirm current status in practice references.

Paracetamol pack sizes (changed 1 February 2025)

Paracetamol is the clearest live example of scheduling being used to manage a toxicological risk, and it is highly examinable because the rules changed recently. From 1 February 2025:

Blister packaging is required for paracetamol tablets and capsules, because slowing consumption reduces impulsive overdose. Some jurisdictions apply tighter local rules — in Queensland and Western Australia a customer must consult a pharmacist for packs larger than 16.

Exam framing: the same active ingredient sits in different schedules purely on pack size and presentation. Do not answer a scheduling question from the drug name alone — read the quantity in the stem.

Migraine triptans (selected products/packs)

Some triptan presentations are available as S3 with strict pharmacist assessment (confirm diagnosis pattern consistent with migraine, cardiovascular risk screening, quantity limits, counselling on when to seek medical care). Exam traps include supplying for undifferentiated severe headache without assessment, ignoring cardiovascular contraindications, or treating a first severe sudden headache as routine migraine.

Emergency contraception (selected products)

Certain emergency contraceptive medicines are S3. Pharmacist involvement typically includes timing since unprotected intercourse, other medicines that affect efficacy, counselling on vomiting/repeat dose rules, ongoing contraception, and STI considerations—while maintaining privacy and non-judgmental care. Age and local supply rules must be applied carefully; do not invent barriers that are not legal requirements, and do not skip required counselling.

Pseudoephedrine-containing products

Pseudoephedrine is tightly controlled because of diversion risk into illicit manufacture. In community pharmacy:

• Products may be S3 (or otherwise restricted depending on presentation and jurisdiction)
• Recording of supply and proof-of-identity requirements commonly apply (Project STOP and state systems are widely used)
• Quantity limits and professional judgment about legitimate therapeutic need are central
• State and territory variations exist—the intern exam expects awareness that recording/ID rules are real and must be followed locally, not a single memorised national form number

Exam trap: Selling pseudoephedrine-containing cold products "like normal OTC" without pharmacist involvement, ID/recording where required, or assessment of therapeutic need.

Recording Requirements (Where Relevant)

Not every S2/S3 sale needs a full poisons register entry, but some do. In general:

• Know which products in your pharmacy trigger mandatory electronic or manual recording
• Capture required fields accurately (identity details, product, quantity, date, pharmacist)
• Never back-fill fake records to "make the sale work"
• Understand that recording supports both clinical continuity and diversion control

Advertising and Storage Differences (High Level)

High-Yield Exam Traps

1. Treating S3 like ordinary OTC — failing to involve the pharmacist or assess the patient
2. Missing age or quantity limits — especially paediatric use and multi-pack requests
3. Failing to counsel — dose, maximum daily amounts, duration, when to see a doctor
4. Ignoring interactions — for example serotonergic risk combinations with certain migraine therapies, or decongestant risks in uncontrolled hypertension
5. Assuming national uniformity of every recording field — principles are national; operational detail is jurisdictional
6. Confusing schedule with PBS — S2/S3 status is about poisons scheduling, not PBS subsidy

Decision Algorithm for S2/S3 Stems

1. Identify the schedule of the requested product/presentation
2. If S3, ensure pharmacist assessment occurs
3. Screen for red flags, age, quantity, interactions, misuse
4. Apply any recording/ID rules
5. Supply with counselling, or refuse and refer
6. Document according to legal and workplace requirements

Mastering this algorithm is more valuable than memorising every brand name on the schedule.